Investigating the Serum Levels of Glutathione and Iron and the Activity of Caspase 3 in Patients with Hashimoto’s Thyroiditis

Document Type : Original Article (s)

Authors

1 MSc Student, Department of Biochemistry, Islamic Azad University, Falavarjan Branch, Isfahan, Iran

2 Assistant Professor, Department of Biochemistry, Islamic Azad University, Falavarjan Branch, Isfahan, Iran

Abstract

Background: Considering the prevalence of thyroid dysfunction and diseases such as Hashimoto's thyroiditis and Graves' disease in the Dezful city, Iran, this study aimed to evaluate the effect of Hashimoto's thyroiditis on serum levels of glutathione and iron and the activity of caspase-3.Methods: In this case-control study, 44 patients with Hashimoto's thyroiditis and 44 healthy controls were studied. The serum levels of glutathione and iron and the activity of caspase-3 were measured. The results were analyzed using Mann-Whitney test via SPSS software.Findings: The amount of serum Fe was significantly lower in patients (P = 0.041). The glutathione level in healthy people was lower; but tests showed no significant difference (P = 0.502). The caspase-3 enzyme activity in healthy subjects was lower; but Mann-Whitney test showed no significant difference (P = 0.089).Conclusion: In patients with Hashimoto's thyroiditis in hypothyroidism phase, the serum iron level was significantly lower than the control group. In addition, the mean serum glutathione level wsa not significantly different between the groups.

Keywords


  1. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160(4): 526-34.
  2. Swain M, Swain T, Mohanty BK. Autoimmune thyroid disorders-An update. Indian J Clin Biochem 2005; 20(1): 9-17.
  3. Singh J, Bashir Sh, Hafiz Khan A, Sharma Sh, Rasool M, Rasheed A. Cytological and clinical correlation of Hashimoto's thyroiditis: a four year experience in a tertiary hospital. International Journal of Advanced Research 2014; 2(1): 418-21.
  4. Staii A, Mirocha S, Todorova-Koteva K, Glinberg S, Jaume JC. Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res 2010; 3(1): 11.
  5. Seth R, Mathur P, Kothiyal P. Vitamin D and thyroid: a new horizon. International Journal of Universal Pharmacy and Bio Sciences 2014; 3(5): 315-28.
  6. Chistiakov DA. Immunogenetics of Hashimoto's thyroiditis. J Autoimmune Dis 2005; 2(1): 1.
  7. Hiromatsu Y, Satoh H, Amino N. Hashimoto's thyroiditis: history and future outlook. Hormones (Athens) 2013; 12(1): 12-8.
  8. Yoshihara A, Yoshimura NJ, Nakachi A, Ohye H, Sato S, Sekiya K, et al. Severe thyroid-associated orbitopathy in Hashimoto's thyroiditis. Report of 2 cases. Endocr J 2011; 58(5): 343-8.
  9. Green DR, Kroemer G. Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest 2005; 115(10): 2610-7.
  10. Iddah MA, Macharia BN. Autoimmune thyroid disorders. ISRN Endocrinology 2013; 2013: 509764.
  11. Banday TH, Bhat SB, Bhat SB, Shah N, Bashir Sh. To study prevalence of incipient iron deficiency in primary hypothyroidism. Int J Res Med Sci 2014; 2(2): 472-5.
  12. Ramirez DJN, Vergara-Villaluz JC, Pilar M, Jasul GV, Anel-Quimpo JS. Prevalence of thyroid dysfunction among individuals taking glutathione supplementation: a cross-sectional study preliminary report. Philippine Journal of Internal Medicine 2010; 48(3): 1-6.
  13. Onat A, Gonenc A, Gurcan S, Torun M. Iron metabolism in patients with impaired thyroid function. J Fac Pharm Ankara 2003; 32(4): 221-30.
  14. Bretz JD, Baker JR, Jr. Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? Clin Endocrinol (Oxf) 2001; 55(1): 1-11.
  15. Mishunina TM, Kalinichenko OV, Tronko MD, Statsenko OA. Caspase-3 activity in papillary thyroid carcinomas. Exp Oncol 2010; 32(4): 269-72.
  16. Bal CS, Kumar A, Chandra P. Effect of iopanoic acid on radioiodine therapy of hyperthyroidism: long-term outcome of a randomized controlled trial. J Clin Endocrinol Metab 2005; 90(12): 6536-40.
  17. Arikan E, Sabuncu T, Sabuncu T, Iynem H, Akcay T, Hatemi H. The effects of hyperthyroidism on lipid peroxidation, erythrocyte glutathione and glutathione peroxidase. Turkish Journal of Endocrinology and Metabolism 2001; 5(1): 17-9.
  18. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344(8924): 721-4.
  19. Colzani RM, Alex S, Fang SL, Stone S, Braverman LE. Effects of iodine repletion on thyroid morphology in iodine and/or selenium deficient rat term fetuses, pups and mothers. Biochimie 1999; 81(5): 485-91.